Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 22, 2021

View Archived Issues

Uncovering the roles of enteric glial cells in intestinal homeostasis, immunity and tissue repair

ARID1A is a marker of endometriosis progression

BUD13 identified as candidate gene in specific language impairment

Targeting GSDMD-mediated pyroptosis as therapeutic strategy for endometriosis

Fujifilm patents HDAC6 inhibitors

Merck & Co. divulges new coagulation factor XIa inhibitors

Takeda Pharmaceutical synthesizes new somatostatin SST4 receptor agonists

Enyo Pharma presents ICD inducers

Researchers identify new GPR52 agonists

GLI1 inhibition as a novel strategy for the treatment of uterine leiomyosarcoma

Loxo Oncology details discovery and testing of PI3Kalpha and FGFR inhibitors

SLFN11 predicts treatment response to TAS-1553 in AML

Purnovate selects PNV-5030 as lead compound in pain program

Cedilla announces lead programs focused on conditional inhibition of TEAD and CDK2

Ligand grants CRDC Asian rights to develop COVID-19 antiviral using BEPro technology

Atreca and Gates MRI enter licensing agreement on MAM-01 for malaria

Splice variant in DEGS1 leads to hypomyelinating leukodystrophy-like phenotype

Regeneron ADC REGN3124-PBD prolongs survival in mice with intracranial glioblastoma tumors

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
Neutrophils put the brakes on fat loss
BioWorld Science
Fat tissue balances energy by storing lipids during times of abundance and mobilizing them when needed, yet sustained metabolic stress demands mechanisms that...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Peptidream reveals milestone in Alnylam collaboration
BioWorld Science
Peptidream Inc. has announced a preclinical development milestone in its collaboration with Alnylam Pharmaceuticals Inc. under their siRNA conjugate discovery...